期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

抵抗素与脑血管病

下载PDF
导出
摘要 抵抗素是脂肪细胞分泌的一种多肽类激素。目前,针对抵抗素的研究大部分集中在肥胖和2型糖尿病方面,对于脑血管病方面的研究极为有限。抵抗素与多种脑血管病发病危险因素相关,因此,抵抗素可能与脑血管病的发生有关。
作者 孙忠玲 赵仁亮
机构地区 青岛大学医学院附属医院神经内科
出处 《国外医学（老年医学分册）》 2006年第6期259-262,共4页 Foreign Medical Sciences(Geriatrics)
关键词 抵抗素 脑血管病 危险因素
分类号 R743.3 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献25

  • 1Stepan CM,Bailey ST,Bhat S et al.The hormone resistin links obesity to diabetes.Nature,2001; 409:307 ～312
  • 2Patel SD,Rajala MW,Rossetti L et al.Disulfide-dependent multimerie assembly of resistin family hormones.Science,2004; 304 (5674):1154
  • 3Banerjee RR,Lazar MA.Dimerization of resistin and resistin-like molecules is determined by a single cysteine.J Biol Chem,2001; 276 (17):25970～25973
  • 4Chosh S,Singh AK,Aruna B et al.The genomic organization of mouse resistin reveals major difference from the human resistin function implication.Gene,2003; 305:27 ～34
  • 5Morash BA,Willkinson D,Ur E et al.Resistin expression and regulation in mouse pituitary.FEBS Lett,2002; 526:26 ～ 30
  • 6Mcternan CL,Mcternan P G,Harte AL et al.Resistin,central obesity,and type 2 diabets.Lancet,2002; 359(5) 46～47
  • 7Savage DB,Sewter CP,Klenk ES et al.Resistin/Fizz 3 ex.pression in Relation to Obesity and Proxisom e Proliferator-Activated Receptor Action in.Human Diabetes,2001; 50:2199
  • 8Azuma K,Ratsukawa F,Oguchi S et al.Corrlation between serum resistin level and adiposity in obese individuals.Obes Res,2003; 11 (8):997
  • 9Kim KH,Lee K,Moon YS et al.A cyseine -rich adipose tissue specific secretory factory inhibits adipocyte differentiation.J Biol Chem,2001; 276 (6):11252～11256
  • 10Hartman HB,Hu X,Tyier KX et al.Mechanisms regulating adipocyte expression of resistin.J Biol Chem,2002;277:19754 ～ 19761

二级参考文献35

  • 1中华神经科学会 中华神经外科学会.各类脑血管疾病诊断要点[J].中华神经外科杂志,1997,13:3-3.
  • 2[1]Steppan CM, Bailey ST, Bchat S et al. The hormone resistin links obesity to diabetes. Nature, 2001, 409:307
  • 3[2]Steppan CM, Yamazawa T, Brown EJ et al. Antagonism of insulin action by resistin. Diabetes, 2001, 50(Suppl 2):A70
  • 4[3]Ferrannini E, Natali A, Capaldo B et al. Insulin resistance, hyperinsulinemia, and blood pressure. Role of age and obesity. Hypertension,1997, 30:1144
  • 5[4]Deurenberg P, Weststrate JA, Seidell JC. Body mass index as a measure of body fatness: age-and sex-specific predition formulas. Br J Nutr,1991, 65:105
  • 6Jove M, Planavila A, Cabrero A, et al. Reductions in plasma cholesterol levels after fenofibrate treatment are negatively correlated with resistin expressionin human adipose tissue. Metabolism. 2003, 52 (3) :351.
  • 7Verma S, Li SH, Wang CH, et al. Resistin promotes endothelial cell activation: further evidence of adipokine - endothelial interaction. Circulation. 2003, 108(6):736.
  • 8Brunetti L, Orlando G, Recinella L, et al. Resistin, but not adiponectin, inhibits dopamine and norepinephrine release in the hypothalamus. Eur J Pharmacol. 2004, 493(1-3) :41.
  • 9Fehmann HC, Heyn J. Plasma resistin levels in patients with type 1and type 2 diabetes mellitus and in healthy controls. Horm Metab Res.2002, 34(11 - 12) :671.
  • 10Youn BS, Yu KY, Park HJ, et al. Plasma resistin concentrations measured by enzyme - linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2004, 89(1):150.

共引文献33

国外医学（老年医学分册）
2006年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部